Which of the following is NOT a core component of the WHO's global STI control strategy?
What is the primary objective of the National STI Control Program?
A sexually active 16-year-old presents for STI screening with recent assault history, multiple partners, inconsistent condom use. Which comprehensive prevention strategy is most appropriate?
A 23-year-old woman is diagnosed with chlamydia. Her partner refuses testing. What contact tracing approach is most appropriate?
Why is partner notification crucial in STI control?
What is the most effective method for preventing sexual transmission of HIV?
Why is the syndromic approach recommended for managing genital ulcers in resource-limited settings?
An 18-year-old girl is brought to the emergency department because of a 1-day history of severe headache with photophobia and diffuse myalgias. She is a college student and lives in a dormitory in a large urban area. She has not traveled recently. On arrival, she is lethargic. Her temperature is 39.3°C (102.7°F), pulse is 120/min, and blood pressure is 88/58 mm Hg. Examination shows scattered petechiae and ecchymoses on the trunk and lower extremities. There is decreased range of motion of the neck. Cerebrospinal fluid analysis shows a cell count of 1,600/μL (80% neutrophils) and a lactate concentration of 5.1 mmol/L. Which of the following is most likely to have prevented this patient's condition?
In Africa, vaccination was given in an endemic outbreak area for a specific disease but due to shortage of vaccines, mass chemoprophylaxis treatment was given to people who were not diseased. Which type of prevention is this?
N95 mask is used for:
Explanation: ***Universal mandatory screening*** - While screening is part of STI control, **universal mandatory screening** for all STIs in the general population is not a core component of the WHO's strategy due to feasibility, cost, and ethical considerations. - The strategy emphasizes **targeted screening** for at-risk populations and opportunistic screening. *Case management* - **Case management**, including accurate diagnosis and effective treatment, is a critical component for managing current infections and preventing further transmission. - This involves syndromic or etiologic approaches to treatment and partner notification. *Strategic information systems* - **Strategic information systems** are essential for monitoring trends, evaluating interventions, and informing policy decisions related to STI control. - This includes surveillance data, program monitoring, and research. *Prevention services* - **Prevention services** are a cornerstone of the WHO's strategy, aiming to reduce the incidence of new infections. - These services encompass health education, condom promotion and distribution, vaccination, and pre-exposure prophylaxis (PrEP).
Explanation: ***Prevention and control of STI transmission*** - The fundamental goal of the National STI Control Program is to **minimize the spread** of sexually transmitted infections. - This involves strategies to **reduce incidence** and **prevalence** through various public health interventions. *Research on new treatments* - While research is important for advancing STI management, it is typically a **secondary or supporting activity**, not the primary objective of a control program. - The main focus of a control program is on **direct public health impact** through existing knowledge and tools. *Contact tracing only* - **Contact tracing** is a critical component of STI control, but it is one strategy among many. - It is not the sole objective; comprehensive programs include **education, testing, and treatment**. *Providing free medications* - **Providing free medications** is a crucial part of accessible treatment, which contributes to control efforts. - However, it's a *means to an end* rather than the overarching primary objective, which is the **prevention and control of transmission**.
Explanation: ***HPV vaccination, counseling, PrEP evaluation, and regular screening*** - This option offers a **comprehensive approach** addressing multiple risk factors and potential exposures, including **vaccination** for HPV, **counseling** for risk reduction, **PrEP evaluation** for HIV prevention due to multiple partners and inconsistent condom use, and **regular screening** for early detection. - The patient's history of **sexual assault**, **multiple partners**, and **inconsistent condom use** necessitates a multi-faceted prevention strategy that goes beyond basic screening. *Condoms and annual screening* - While **condoms** are essential for preventing STIs, and **annual screening** is important, this strategy is not comprehensive enough given the patient's high-risk profile (multiple partners, inconsistent condom use, sexual assault history). - It omits important preventive measures like **HPV vaccination** and consideration for **PrEP**, which are crucial for this patient's age and risk factors. *Single STI screen and treatment if needed* - A **single STI screen** is insufficient as it only provides a snapshot of current infections and does not incorporate **prevention strategies** for future encounters or address the ongoing risk factors. - This approach fails to provide **proactive protection** through vaccination or PrEP and does not include ongoing counseling for risk reduction. *Abstinence counseling only* - While **abstinence** is the most effective way to prevent STIs, relying solely on **abstinence counseling** is often unrealistic and insufficient for a sexually active individual, especially one with a history of sexual assault and current high-risk behaviors. - This option completely disregards the need for **medical interventions** like vaccination, PrEP, and regular screening that are vital for this patient's health.
Explanation: ***Expedited partner therapy (EPT)*** - This approach allows clinicians to provide medication or a prescription for a partner without a prior medical examination, facilitating treatment when a partner is unwilling or unable to seek care. - It is particularly useful for **chlamydia** and **gonorrhea** to reduce reinfection rates and further transmission. - **Recommended by CDC and WHO** for STI partner management when partners are unlikely to present for care. - *Note: EPT implementation varies by country; in India, partner notification with clinical evaluation is standard practice, but EPT represents the most direct approach when partners refuse testing.* *Patient referral only* - Relying solely on the patient to inform and encourage their partner to seek testing and treatment can be effective but carries a risk of the partner not following through, leading to continued transmission. - This method might be less successful if the partner is uncooperative or unwilling to get tested, as is implied in this scenario. - **Most commonly used approach** in resource-limited settings but has lower success rates. *Contract referral* - Involves the patient agreeing to notify their partner, with the understanding that if the partner does not present for treatment within a specified timeframe, health officials will then intervene. - While it offers a backup, it still relies on initial patient action and may not be immediate enough when a partner is actively refusing testing. - Provides a **safety net** but involves delays in partner treatment. *Provider referral only* - This method involves a healthcare provider directly contacting the partner to inform them of exposure and recommend testing and treatment, respecting patient confidentiality. - This option is generally preferred when there are concerns about the patient's safety or if the patient is unable or unwilling to notify their partner. - More resource-intensive and requires **trained health workers** for partner notification, but ensures partners are reached even if the index patient cannot or will not inform them.
Explanation: ***To break the chain of transmission*** - **Partner notification (PN)** identifies and treats individuals potentially infected through sexual contact with an index patient, thereby preventing further spread of the **STI**. - This proactive approach ensures that asymptomatic or unaware partners are diagnosed and treated, effectively interrupting the continuous cycle of **STI transmission** within a community. *To improve compliance* - While PN can encourage partners to seek testing and treatment, its primary goal is not patient compliance with an existing treatment regimen. - Compliance improvement is usually addressed through direct patient education and follow-up, rather than through notifying sexual partners. *To track resistance patterns* - Tracking resistance patterns involves laboratory surveillance of STI pathogens through culture and sensitivity testing, which is separate from the public health intervention of partner notification. - PN focuses on identifying infected individuals for treatment, not on monitoring the antimicrobial susceptibility of circulating strains. *To reduce treatment costs* - Although widespread treatment through PN might reduce the long-term societal burden of STIs and associated complications, its direct and immediate purpose is not cost reduction. - The primary aim is disease control and prevention of severe health outcomes, even if initial costs for testing and treatment might increase.
Explanation: ***Complete abstinence*** - **Abstinence** from sexual activity entirely eliminates the risk of sexually transmitted HIV, making it the most effective preventive measure. - As HIV is primarily transmitted through the exchange of bodily fluids during sexual contact, the absence of such contact prevents transmission. *Consistent condom use* - While highly effective when used correctly and consistently, **condoms can fail** due to breakage, incorrect use, or non-use, hence not 100% effective. - It significantly reduces the risk but does not eliminate it entirely, as there's still potential for exposure if a condom is not used at every sexual encounter or if there is contact with infected fluids outside the condom. *Post-exposure prophylaxis* - **PEP involves taking antiretroviral drugs after potential exposure** to HIV to prevent infection. It is a treatment, not a primary prevention method. - It is effective in reducing the risk of seroconversion if initiated within 72 hours of exposure but is not a guaranteed prevention strategy and should not be relied upon as the sole method. *Regular STI screening* - **Regular screening for sexually transmitted infections (STIs)** can help identify and treat other STIs that might increase the risk of HIV transmission (e.g., ulcerative STIs). - However, screening itself does not prevent HIV transmission; it is a component of comprehensive sexual health care rather than a direct barrier to HIV infection.
Explanation: ***Because it allows immediate treatment without waiting for lab results*** - The syndromic approach enables healthcare providers to **initiate treatment immediately** based on the clinical presentation of genital ulcer disease - This is crucial in resource-limited settings where laboratory testing for specific pathogens might be **unavailable, costly, or time-consuming**, preventing delays in care - Immediate treatment reduces transmission, prevents complications, and improves patient outcomes *Because it improves contact tracing* - While contact tracing is an important aspect of sexually transmitted infection (STI) management, the syndromic approach primarily focuses on **patient treatment** rather than directly improving contact tracing methods - It does not inherently facilitate the identification and notification of sexual partners any more effectively than other diagnostic methods *Because it's more cost-effective than testing* - The syndromic approach is indeed often **more cost-effective** than laboratory testing, especially in settings with limited resources - However, the primary driving reason for its recommendation is the ability to provide **rapid treatment** without diagnostic delays, thereby preventing further transmission and complications *Because it prevents antimicrobial resistance* - The syndromic approach involves empiric treatment, meaning broad-spectrum antibiotics are used to cover the most common causes of genital ulcers - This approach, if not carefully managed, can actually **contribute to antimicrobial resistance** due to the potential for overuse or misuse of antibiotics - This is why the syndromic approach does NOT prevent antimicrobial resistance
Explanation: ***Polysaccharide conjugate vaccine*** - This patient presents with symptoms highly suggestive of **bacterial meningitis** and **septic shock**, likely caused by *Neisseria meningitidis*, given the petechiae, ecchymoses, and rapid deterioration. - A **meningococcal conjugate vaccine** would have provided protection against most common serogroups of *N. meningitidis* (A, C, W-135, Y) and is strongly recommended for college students living in dormitories due to increased risk of transmission. *Intravenous vancomycin* - This is an **acute treatment** for bacterial meningitis, specifically active against *Streptococcus pneumoniae* and some resistant strains. - It would not have **prevented** the condition; preventative measures are typically vaccines or prophylactic antibiotics. *Erythromycin therapy* - Erythromycin is an antibiotic used for various bacterial infections, including atypical pneumonia and some skin infections. - It is **not the primary prophylactic agent** for meningococcal disease and would not have prevented this specific condition. *Doxycycline therapy* - Doxycycline is a broad-spectrum antibiotic used for a range of infections, including tick-borne diseases and certain respiratory infections. - It is **not indicated for the prevention** of meningococcal meningitis. *Toxoid vaccine* - **Toxoid vaccines** protect against diseases caused by bacterial toxins, such as tetanus and diphtheria. - *Neisseria meningitidis* causes disease primarily through direct invasion and immune response to its capsular polysaccharides, not primarily exotoxins, so a toxoid vaccine would not be effective here.
Explanation: ***Specific protection*** - **Vaccination** directly prevents disease, fitting into the criteria of specific protection. - **Mass chemoprophylaxis** aims to prevent disease in healthy individuals in an endemic area, which is also a form of specific protection. *Rehabilitation* - This involves measures to restore function and well-being after a disease has occurred and caused disability. - It does not involve preventing the initial onset of disease, as described in the scenario. *Health promotion* - Health promotion includes broad interventions like education, lifestyle changes, and environmental modifications to improve overall health and prevent disease indirectly. - It is not as targeted as vaccination or chemoprophylaxis against a specific disease. *Early diagnosis and treatment* - This level of prevention focuses on identifying and treating a disease in its early stages to prevent its progression and complications. - The scenario describes preventing disease in healthy individuals, not treating existing cases.
Explanation: ***aerosol*** - **N95 masks** are specifically designed to filter out at least 95% of **airborne particles** (aerosols) 0.3 microns or larger. - This level of filtration is crucial for protecting against diseases transmitted via **aerosolized droplets**, such as tuberculosis or COVID-19. *respiratory droplets* - While an N95 mask can filter respiratory droplets, it is primarily designed for smaller **aerosol particles** that can remain suspended in the air. - **Surgical masks** are generally adequate for blocking larger respiratory droplets, preventing splash and splatter. *Dust* - While an N95 mask can filter dust, it is an **overkill** for most common dust exposures. - A simple **dust mask** or even a surgical mask can provide adequate protection against larger dust particles. *in general* - This option is too broad; N95 masks are specifically used when there's a risk of exposure to **aerosolized infectious agents** or **fine particulate matter**. - Their use is typically reserved for settings where **aerosol-generating procedures** are performed or when caring for patients with **airborne diseases**.
Communicable Disease Control Principles
Practice Questions
Vector-Borne Diseases
Practice Questions
Water-Borne Diseases
Practice Questions
Air-Borne Diseases
Practice Questions
Zoonotic Diseases
Practice Questions
Sexually Transmitted Infections
Practice Questions
HIV/AIDS Control Program
Practice Questions
Tuberculosis Control
Practice Questions
Leprosy Elimination
Practice Questions
Emerging and Re-emerging Infections
Practice Questions
Hospital-Acquired Infections
Practice Questions
Integrated Disease Surveillance Project
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free